The Taliban government has introduced sweeping reforms in Afghanistan’s pharmaceutical market to improve drug quality and boost domestic production. The move follows a November announcement to end long-standing dependence on medicine imports from Pakistan after deadly border clashes. Importers were given three months to find alternative legal sources, but traders report major challenges in ending old contracts and completing customs procedures.

Pharmacists in Kabul say prices of several medicines have risen while some drugs are unavailable, causing hardship for patients. Transport costs have surged by up to 30 percent as imports shift to routes through Iran and other countries. The Health Ministry cites counterfeit Pakistani medicines as a key reason for the reform and says new supply links are being built with Iran, India, Bangladesh, Uzbekistan, Turkey, China, and Belarus. Local firms now produce about 600 types of medicines, including antibiotics.

Experts caution that Afghanistan remains dependent on imported raw materials and faces high energy costs and limited infrastructure, making full self-sufficiency unrealistic in the short term. Doctors warn that the transition is complicating treatment and delaying patient care.